Thoratec announces First HeartMate III Human Implant and start of CE Mark trial
Thoratec said that its CE Mark Clinical Trial for HeartMate III commenced with the first patient implanted with this new device. HeartMate III is a centrifugal-flow chronic left ventricular assist system. The fully magnetically levitated technology foundation of HeartMate III is designed to lower adverse event rates through improved hemocompatibility while enhancing ease of surgical placement through a compact size.
Terms and Privacy Policy